Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26FXNE8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,990
Award facts
- Contract value 100% obligated
- $1,989.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,989.95 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) Pen 40 mg/0.4 mL, a biologic immunosuppressant medication used to treat various autoimmune conditions. This firm fixed-price contract, awarded November 24, 2025, with an ultimate completion date of November 25, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen Drug Corp's prime IDC with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military and federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen provides a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency and other government healthcare programs globally. The company's federal contract portfolio demonstrates consistent success in competitively winning and executing firm fixed-price delivery orders across multiple therapeutic domains and product categories.
Quick answers
Who was awarded contract SPE2DR26FXNE8?
SPE2DR26FXNE8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FXNE8 worth?
The government has obligated $1,990 on SPE2DR26FXNE8.
Is contract SPE2DR26FXNE8 an order under another contract?
Yes. SPE2DR26FXNE8 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXNE8 competed?
The extent of competition for SPE2DR26FXNE8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award